Summary The aim of this study was to determine the mechanism of cell death associated with the preferential killing of multidrug-resistant (MDR) cells by the glycolytic inhibitor 2-deoxy-D-glucose (2DG) in a range of MDR human KB carcinoma cell lines selected in different drugs. The D10 values for KB-Vl, KB-Cl and KB-Al (selected in vinblastine, colchicine and doxorubicin respectively) were 1.74, 1.04 and 0.31 mM, respectively, compared with 4.60 mm for the parental cell line (KB-3-1). The mechanism of cell death was identified as apoptosis, based on nuclear morphology, annexin V binding and poly(ADP-ribose) polymerase (PARP) cleavage. 2DG induced apoptosis in the three MDR cell lines in a dose-and time-dependent manner and did not induce necrosis. PARP cleavage was detected in KB-Cl cells within 2 h of exposure to 50 mM 2DG and slightly later in KB-Al and KB-Vl cells. The relative levels of 2DG sensitivity did not correlate with the levels of multidrug resistance or with the reduced levels of the glucose transporter GLUT-1 in these cells. We speculate that a 2DG-stimulated apoptotic pathway in MDR KB cells differs from that in normal KB cells.
Multidrug resistance, involving cross-resistance to chemotherapeutic drugs, is thought to be a significant obstacle in the successful treatment of several haematological malignancies Malayeri et al, 1996) and is likely to contribute to resistance in certain solid tumours (Bellamy and Dalton 1994; Shustik et al, 1995; Trock et al, 1997) . It is frequently mediated by overexpression of the P-glycoprotein (Pgp), which functions as an ATP-dependent drug-efflux pump (Gottesman and Pastan, 1993; Germann, 1996) .
The development of multidrug resistance in cancer cells is accompanied by other changes that are potentially exploitable for their selective killing. It is often associated with an increased rate of glycolysis (Jain et al, 1985; Cohen and Lyon, 1987) . Even in the absence of increased glycolytic rates relative to parental cells, glycolysis is the main energy-yielding pathway in multidrugresistant (MDR) cells (Lyon et al, 1988; Fanciulli et al, 1993; Rasmussen et al, 1993) . These observations suggest the possibility of selective killing of MDR cells by glycolytic inhibitors, e.g. 2-deoxy-D-glucose (2DG).
2DG is a glucose analogue that acts by competitively inhibiting glucose uptake, mediated by the facilitative glucose transporter GLUT-1. It inhibits glucose utilization via its metabolic product 2-deoxy-D-glucose-6-phosphate, which blocks phosphoglucose isomerase and results in cellular ATP depletion (Wick et al, 1957) .
2DG has been shown to be preferentially toxic to a range of MDR cell lines, and there is a good correlation between the level of multidrug resistance and 2DG sensitivity in cells selected with the same agent (Kaplan et al, 1990 (Kaplan et al, , 1991 Bentley et al, 1996) . In the colchicine-selected series KB-8-5, KB-8-5-11 and KB-Cl, we have shown that the development of multidrug resistance is Received 10 October 1997 Revised 20 March 1998 Accepted 22 April 1998 Correspondence to: JR Warr accompanied by a decrease in the expression of and proposed that the increased energy demand and glucose dependency in MDR cells, in combination with lower GLUT-I transporter levels, renders MDR cells preferentially sensitive to the antiglycolytic effects of 2DG (Bentley et al, 1996) . However, in cells selected with different cytotoxic agents, e.g. KB-Al and KB-VI (selected in doxorubicin and vinblastine respectively), there is no correlation between the level of multidrug resistance and 2DG sensitivity (Kaplan et al, 1991) . This suggests that drug selection induces other changes, in addition to Pgp expression, that are involved in determining the cellular response to 2DG exposure.
The preferential susceptibility of MDR cells to 2DG or to other treatments implies that such cells have properties that may ultimately be exploited to kill MDR cells in vivo. To achieve this objective, it is important to characterize the nature of the differential killing of MDR cells and to understand the reasons for its occurrence. A fundamental step towards this goal is to establish whether the underlying mechanism of 2DG-induced cell death in MDR cells is by necrosis or by apoptosis. Because apoptosis is an orderly process whereby the cell takes an active role in its own destruction (reviewed by Hale et al, 1996; Umansky, 1996) , the occurrence of preferential cell death by apoptosis may offer additional targets to modulate and amplify this process, and so lead to useful levels of selective killing of MDR cells under clinical conditions.
The aim of this work, therefore, was to identify and characterize the underlying mechanism of 2DG-induced cell death in a range of MDR human KB carcinoma cell lines, selected with different cytotoxic agents, as a step towards this long-term goal of maximizing the selective killing of MDR cells.
MATERIALS AND METHODS Cell culture
The human epidermal carcinoma cell line KB-3-1 and its multidrug-resistant sublines (KB-Cl, KB-VI and KB-Al) were donated by Dr MM Gottesman, or purchased from the American Tissue Culture Collection. KB-Cl, KB-VI and KB-Al cell lines were isolated from the KB-3-1 cell line by selection by single agents: colchicine, vinblastine and doxorubicin respectively (Akiyama et al, 1985; Shen et al, 1986) . The cell lines were cultured in Dulbecco's modified Eagle medium (DMEM) containing 25 mm glucose (Gibco), supplemented with 10% fetal bovine serum (Gibco), 50 U ml-' penicillin and 50 ,ug ml-' streptomycin (Sigma) in 5% carbon dioxide at 37°C. KB-Cl, KB-Vl and KB-Al cell lines were routinely maintained in 1 ig ml-' colchicine, vinblastine and doxorubicin respectively. All cell lines were grown in drug-free medium for 3 days before experiments.
Clonogenic cytotoxicity assay
Cells were seeded in 24-well plates, in the indicated concentrations of 2DG or anti-cancer drug, at a density of 100 (KB-3-1 and KB-Cl), 200 (KB-VI) or 300 (KB-Al) cells per well. After 8 days' incubation, the cells were fixed and stained with Leishman stain (2 g 1-1 in methanol) for 40 min, then rinsed in water. The number of colonies (> 50 cells) was counted and expressed as a percentage of the drug-free controls.
Analysis of GLUT-1 levels
Plasma membrane fractions were isolated as described by Harrison et al (1990) . GLUT-1 levels were determined by Western blot analysis and quantified by densitometry (Bentley et al, 1996) .
Apoptosis induction
Cells were seeded in six-well (for microscopy) or 12-well (for flow cytometry) plates and cultured in drug-free DMEM for 3 days.
For UV irradiation, DMEM was removed from each well and the monolayer rinsed with phosphate-buffered saline (PBS). The cells were irradiated with 200 J m-2 UV in a Stratalinker UV Crosslinker 1800 (Stratagene). Fresh DMEM was then added and the cells returned to the incubator for 4 h.
For 2DG treatment, fresh DMEM containing the appropriate concentrations of 2DG was added to the exponentially growing cells and culture continued for the indicated time (up to 24 h). Control cells for both treatments were refed with fresh DMEM. (Koopman et al, 1994) . Annexin V-FITC (BioWhittaker), which binds to exposed phosphatidylserine (PS), was added to a final concentration of 2 ,ug ml-' and incubated for 10 min in the dark at room temperature. Unbound annexin V-FITC was removed by washing twice in binding buffer and the final cell pellet was resuspended in approximately 50 gl of binding buffer. Samples to be analysed by fluorescence microscopy were additionally stained with the DNA dye Hoechst 33342 (Ho342) (16 ,ug ml-') for 10 min at 37°C. After staining, all samples were kept on ice in the dark. To identify cells that had lost plasma membrane integrity, propidium iodide (PI) (10 jg ml-') was added immediately before analysis. Labelled cells were analysed by fluorescence microscopy or flow cytometry. The cytotoxic effect of 2DG on three MDR cell lines, KB-C l, KB-VI and KB-Al (selected with different agents), compared with their parental non-MDR cell line, KB-3-1, was determined by the colony formation assay. All three MDR cell lines were preferentially killed by 2DG, compared with the parental KB-3-1 cell line (Figure 1) . The D1ovalues for KB-3-1, KB-V1, KB-Cl and KB-Al were 4.60, 1.74, 1.04 and 0.31 mm respectively.
The three MDR cell lines exhibited different levels of sensitivity to 2DG, relative to KB-3-1 cells, that did not correlate with their levels of multidrug resistance (Table 1) . For example, KB-A cells show only moderate resistance to conventional agents but are, by far, the most sensitive of the MDR lines to 2DG.
GLUT-1 transporter levels
Previous work has shown that the levels of the facilitative glucose transporter, GLUT-1, are progressively reduced in colchicineselected MDR cells expressing increasing levels of multidrug resistance (Bentley et al, 1996) . We, therefore, measured the levels of GLUT-I in the three MDR cell lines studied here, each of which had been selected in the presence of a different drug. KB-A1, which is the least multidrug resistant of the cell lines and the most sensitive to 2DG, had a relatively slight reduction in GLUT-I level (0.63 of the control value), whereas KB-V1 and KB-Cl, which are more multidrug resistant but less sensitive to 2DG, had greater reduction in GLUT-l levels (0.37 and 0.48 respectively) (Table 1) . Thus, the reduction in the level of GLUT-I does not correlate with the sensitivity to 2DG.
Mechanism of cell death associated with 2DG cytotoxicity
To identify the mechanism of 2DG-induced cell death in MDR cells, floating and adherent cells (harvested by trypsinization) were pooled and stained with annexin V-FITC, Ho342 and PI, then examined by fluorescence microscopy. Microscopic examination of nuclear morphology and plasma membrane integrity in such stained cells was the method of choice to establish the basic features of 2DG-induced cell death in MDR and control cells because this method will distinguish between necrotic and late apoptotic cells, unlike non-morphological methods. Examination using the UV filter showed that untreated cells exhibited noncondensed nuclei (diffuse blue Ho342), and the majority did not take up PI (Figure 2A) . A significant proportion (quantified below) of 2DG-treated KB-V1, KB-Cl and KB-Al cells underwent nuclear condensation and fragmentation, characteristic features of apoptosis. This is shown for KB-VI in Figure 2C ; similar nuclear condensation was seen in KB-Cl and KB-Al (not illustrated). The apoptotic cell population comprised early apoptotic cells (bright blue fragmented nuclei) and those in the late stages that had lost plasma membrane integrity and, hence, taken up red PI in addition to blue Ho342 (pale pink nuclei) ( Figure 2C ). During the early stages of apoptosis, cells undergo a redistribution of PS from the internal to the external leaflet of the plasma membrane, which can be detected by green annexin V-FITC labelling (Martin et al, 1995) . When examined under the blue and UV filters in turn, the annexin V-FITC-positive cells corresponded to those cells with condensed or fragmented nuclei ( Figure 2D compared with 2C ), indicating that PS had been externalized on the outer surface of cells undergoing the characteristic nuclear condensation associated with apoptosis. Cells with enlarged and diffuse pink nuclei were classed as necrotic (single cell in Figure 2A ).
The validity of this technique for detecting apoptosis was confirmed using UV-irradiated KB-V1 cells as positive controls, because this treatment is a well-documented inducer of apoptosis (Martin and Cotter, 1991) . Treatment of MDR cells with 200 J m-2 UV was shown to produce a similar range of morphological changes as described above for 2DG-treated cells ( Figure 2B ). In a further control, it was shown that trypsinization did not cause the non-apoptosis-induced exposure of PS (data not shown) as has been reported in another adherent cell line (van Engeland et al, 1996) .
The dose-response of 2DG-induced cell death was quantified by examining nuclear morphology and PS exposure in exponentially growing KB-3-1, KB-Al, KB-Cl and KB-Vl cells that had been incubated in increasing concentrations of 2DG for 24 h. 2DG exposure for 24 h did not significantly reduce the proportion of viable KB-3-1 cells over the entire dose range (0-50 mM) ( Figure 3A) . In contrast, in each of the three MDR cell lines, the percentage of cells with apoptotic features increased greatly with increasing doses of 2DG ( Figure 3B-D) . In each MDR cell line, a slight increase in the level of apoptosis could be observed following exposure to 5 mM 2DG, and the level exceeded 60% apoptotic cells following exposure of KB-Cl and KB-Vl cells to 50 mm 2DG. In all four cell lines, the percentage of necrotic cells did not change appreciably, even at the highest doses of 2DG ( Figure 3A-D) . The interleukin-converting enzyme-related protease substrate, PARP, is cleaved from a 113-kDa protein to two fragments of 89 kDa and 24 kDa during many cases of apoptosis (Kaufmann et al, 1993) , and provides further evidence that apoptosis has occurred. PARP was analysed by Western blotting in total cell lysates at time points of up to 24 h exposure to 50 mM 2DG. There was no evidence of PARP cleavage in the parental KB-3-1 cells at any time point ( Figure SA) . However, the appearance of a 89-kDa cleavage product and the diminution of the intact 113-kDa molecule was evident in the 2DG-treated KB-Cl cells from 2 h onwards ( Figure SC) . PARP cleavage was also apparent in 2DG-treated KBAl and KB-V1 cells ( Figure Anx-ve/Pl-ve (viable) , Anx+ve/PI-ve (early apoptotic) and Anx+ve/PI+ve (late apoptotic and necrotic) cells were quantified by flow cytometry.
In the 2DG-sensitive MDR cell lines, apoptosis was detectable in a small percentage of cells at the earliest measured time point (6 h) following exposure to 2DG, and the percentage of apoptotic cells continued to rise throughout the time course of drug exposure ( Figure 4B-D) . In contrast, the onset of the very slight increase in apoptosis in the KB-3-1 cell line occurred much later and did not rise above 10% after correction for background necrotic levels ( Figure 4A ).
To gain a better understanding of why different MDR cell lines have greater sensitivity to 2DG than normal, and to learn how the preferential killing of such cells may be maximized, the underlying mechanism of their death has been investigated. We have demonstrated by three separate criteria (nuclear morphology, phosphatidylserine exposure and PARP cleavage) that the preferential killing of MDR cells by 2DG occurs by apoptosis, over a wide drug concentration range.
Although 2DG has a preferentially cytotoxic effect on three MDR cell lines (KB-Cl, KB-Vl and KB-Al) selected with different agents, compared with their parental cell line (KB-3-1), there is no direct correlation between the level of multidrug resistance and the level of 2DG sensitivity. This contrasts with our previous finding that the three MDR KB cell lines KB-8-5, KB-8-5-11 and KB-Cl, which were selected in progressively increasing concentrations of the same agent (colchicine), show progressively greater 2DG sensitivity with increasing levels of multidrug resistance (Bentley et al, 1996) . The combination of these results suggests that, although Pgp level may contribute to the extent of 2DG-induced apoptosis in KB cell lines, different selecting agents select for other changes in MDR cells, distinct from those in Pgp expression, which influence the level of their sensitivity to 2DG. Kaplan et al (1990) have shown that 2DG exposure leads to a reduction in ATP levels in MDR and sensitive cells, with a slightly greater reduction in the former. We have previously shown that a reduction in levels of the facilitative glucose transporter, GLUT-1, exists in MDR KB cells (Bentley et al, 1996) , which may potentiate the reduction in ATP in MDR cells. ATP levels are thought to be crucial in signalling for apoptosis (Eguchi et al, 1997) and so depletion of ATP may be a contributory factor in the induction of the apoptotic pathway by 2DG in our cells. However, the lack of correlation between the GLUT-1 level and the extent of sensitivity to 2DG in different cell lines suggests that other mechanisms may also be involved.
It is possible to speculate on the nature of such mechanisms. Lavie et al (1996) have reported that there are higher levels of glucosylceramide in KB-Vl cells than their sensitive counterparts. Metabolites of such glycosphingolipids, such as ceramides, are suggested to have a second messenger function in some signal pathways regulating apoptosis (Hale et al, 1996; Hannun, 1996) . Elevated levels of protein British Journal of Cancer (1998) 78(11), [1464] [1465] [1466] [1467] [1468] [1469] [1470] 0 Cancer Research Campaign 1998 1470 SE Bell et al kinase C (PKC) have also been reported in KB-Al, KB-Cl and KB-V I cells (Drew et al, 1994) . PKC is known to be an important player in intracellular signalling leading to apoptosis, although its precise role is yet to be defined (Hale et al, 1996; Leszczynski, 1996) .
In conclusion, we propose that a 2DG-stimulated apoptotic pathway differs in MDR KB cells from that in normal KB cells. Understanding changes in the pathway involved would provide the basis for rational suggestions of combinations of treatments to maximize the killing of MDR cells. Such studies could be of value in the clinical situation.
